NovaBay Pharmaceuticals, Inc. Repayment/Issuance of Debt (Net)

Repayment/Issuance of Debt (Net) of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Repayment/Issuance of Debt (Net) growth rates and interactive chart.


Highlights and Quick Summary

  • Repayment/Issuance of Debt (Net) for the quarter ending June 30, 2022 was $-117 Thousand (a -106.37% decrease compared to previous quarter)
  • Year-over-year quarterly Repayment/Issuance of Debt (Net) increased by 9.35%
  • Annual Repayment/Issuance of Debt (Net) for 2021 was $48 Thousand (a -101.43% decrease from previous year)
  • Annual Repayment/Issuance of Debt (Net) for 2020 was $-3.37 Million (a -354.0% decrease from previous year)
  • Annual Repayment/Issuance of Debt (Net) for 2019 was $1.33 Million (a -180.12% decrease from previous year)
  • Twelve month Repayment/Issuance of Debt (Net) ending June 30, 2022 was $1.97 Million (a -0.76% decrease compared to previous quarter)
  • Twelve month trailing Repayment/Issuance of Debt (Net) decreased by -740.72% year-over-year
Trailing Repayment/Issuance of Debt (Net) for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
$1.97 Million $1.98 Million $48 Thousand $-307 Thousand
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Repayment/Issuance of Debt (Net) of NovaBay Pharmaceuticals, Inc.

Most recent Repayment/Issuance of Debt (Net)of NBY including historical data for past 10 years.

Interactive Chart of Repayment/Issuance of Debt (Net) of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Repayment/Issuance of Debt (Net) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-0.12 $1.84
2021 $0.36 $-0.11 $-0.1 $-0.1 $0.05
2020 $0.0 $-0.42 $-1.58 $-0.57 $-3.37
2019 $-0.65 $0.0 $0.0 $3.0 $1.33
2016 $0.0 $-0.52 $-2.5 $1.37 $-1.66
2015 $1.66 $1.66
2012 $0.0 $0.0 $0.0 $-0.07 $-0.07
2011 $0.07 $0.0 $-0.04

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology